GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (SHSE:600613) » Definitions » EV-to-EBITDA

Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) EV-to-EBITDA : 32.35 (As of Apr. 26, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Shanghai Shenqi Pharmaceutical Investment Management Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shanghai Shenqi Pharmaceutical Investment Management Co's enterprise value is ¥2,809 Mil. Shanghai Shenqi Pharmaceutical Investment Management Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ¥87 Mil. Therefore, Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA for today is 32.35.

The historical rank and industry rank for Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA or its related term are showing as below:

SHSE:600613' s EV-to-EBITDA Range Over the Past 10 Years
Min: -32.53   Med: 28.98   Max: 69.58
Current: 32.24

During the past 13 years, the highest EV-to-EBITDA of Shanghai Shenqi Pharmaceutical Investment Management Co was 69.58. The lowest was -32.53. And the median was 28.98.

SHSE:600613's EV-to-EBITDA is ranked worse than
84.44% of 707 companies
in the Drug Manufacturers industry
Industry Median: 14.03 vs SHSE:600613: 32.24

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Shanghai Shenqi Pharmaceutical Investment Management Co's stock price is ¥6.30. Shanghai Shenqi Pharmaceutical Investment Management Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ¥0.110. Therefore, Shanghai Shenqi Pharmaceutical Investment Management Co's PE Ratio for today is 57.27.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shanghai Shenqi Pharmaceutical Investment Management Co EV-to-EBITDA Historical Data

The historical data trend for Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shenqi Pharmaceutical Investment Management Co EV-to-EBITDA Chart

Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.67 21.48 -9.04 18.94 22.99

Shanghai Shenqi Pharmaceutical Investment Management Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.35 22.99 44.99 37.26 42.95

Competitive Comparison of Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA

For the Drug Manufacturers - General subindustry, Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA falls into.



Shanghai Shenqi Pharmaceutical Investment Management Co EV-to-EBITDA Calculation

Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2809.321/86.829
=32.35

Shanghai Shenqi Pharmaceutical Investment Management Co's current Enterprise Value is ¥2,809 Mil.
Shanghai Shenqi Pharmaceutical Investment Management Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Shenqi Pharmaceutical Investment Management Co  (SHSE:600613) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shanghai Shenqi Pharmaceutical Investment Management Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.30/0.110
=57.27

Shanghai Shenqi Pharmaceutical Investment Management Co's share price for today is ¥6.30.
Shanghai Shenqi Pharmaceutical Investment Management Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shanghai Shenqi Pharmaceutical Investment Management Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shanghai Shenqi Pharmaceutical Investment Management Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Business Description

Traded in Other Exchanges
Address
128 Weihai Road, Room 613, Changfa Building, Shanghai, CHN, 200003
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.

Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Headlines

No Headlines